Macquarie Group’s ProQR Therapeutics PRQR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.27M | Hold |
620,000
| – | – | ﹤0.01% | 1330 |
|
|
2025
Q1 | $825K | Hold |
620,000
| – | – | ﹤0.01% | 1414 |
|
|
2024
Q4 | $1.64M | Hold |
620,000
| – | – | ﹤0.01% | 1254 |
|
|
2024
Q3 | $1.13M | Hold |
620,000
| – | – | ﹤0.01% | 1355 |
|
|
2024
Q2 | $1.03M | Hold |
620,000
| – | – | ﹤0.01% | 1374 |
|
|
2024
Q1 | $1.41M | Hold |
620,000
| – | – | ﹤0.01% | 1312 |
|
|
2023
Q4 | $1.23M | Hold |
620,000
| – | – | ﹤0.01% | 1337 |
|
|
2023
Q3 | $806K | Hold |
620,000
| – | – | ﹤0.01% | 1382 |
|
|
2023
Q2 | $1M | Hold |
620,000
| – | – | ﹤0.01% | 1355 |
|
|
2023
Q1 | $1.32M | Hold |
620,000
| – | – | ﹤0.01% | 1293 |
|
|
2022
Q4 | $2.29M | Hold |
620,000
| – | – | ﹤0.01% | 1175 |
|
|
2022
Q3 | $461K | Hold |
620,000
| – | – | ﹤0.01% | 1535 |
|
|
2022
Q2 | $482K | Hold |
620,000
| – | – | ﹤0.01% | 1592 |
|
|
2022
Q1 | $561 | Hold |
620,000
| – | – | ﹤0.01% | 1627 |
|
|
2021
Q4 | $4.97M | Hold |
620,000
| – | – | ﹤0.01% | 1120 |
|
|
2021
Q3 | $5.19M | Hold |
620,000
| – | – | ﹤0.01% | 1097 |
|
|
2021
Q2 | $4.18M | Hold |
620,000
| – | – | ﹤0.01% | 1180 |
|
|
2021
Q1 | $4.1M | Buy |
+620,000
| New | +$4.1M | 0.01% | 963 |
|
|
2018
Q1 | – | Sell |
-2,900
| Closed | -$9K | – | 2326 |
|
|
2017
Q4 | $9K | Buy |
+2,900
| New | +$9K | ﹤0.01% | 2279 |
|